Invention Grant
- Patent Title: Plasmid-based CTX phage replication system and vibrio cholerae strain that can be infected by CTX phage and can be used for cholera toxin production
-
Application No.: US16442164Application Date: 2019-06-14
-
Publication No.: US11136358B2Publication Date: 2021-10-05
- Inventor: Dong Wook Kim , Eun Jin Kim , Hyun Jin Yu
- Applicant: INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY ERICA CAMPUS
- Applicant Address: KR Ansan-si
- Assignee: INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY ERICA CAMPUS
- Current Assignee: INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY ERICA CAMPUS
- Current Assignee Address: KR Ansan-si
- Agency: Studebaker & Brackett PC
- Priority: KR10-2016-0172681 20161216,KR10-2016-0172684 20161216,KR10-2017-0144851 20171101
- Main IPC: A61K39/00
- IPC: A61K39/00 ; A61K39/02 ; A61K39/106 ; C07K14/28 ; C12N15/74 ; C12N7/00 ; C12N15/65 ; C12P21/02 ; C12N1/20 ; C12R1/63

Abstract:
The present invention relates to a plasmid-based CTX phage replication system and Vibrio cholerae strain that can be infected by CTX phage and can be used for cholera toxin production. More particularly, the present invention provides a Vibrio cholera variant strain, which expresses a toxT protein in which tyrosine at position 139 is substituted by phenylalanine through the point mutation of a toxT gene using a plasmid-based CTX phage replication system, and is used as a receptor strain which can improve CTX phage infection efficiency and allows a plurality of CTX prophages to simultaneously infect the strain and to be inserted into the chromosome thereof, which the consequent provision of the effect of increasing the production yield of a cholera toxin.
Public/Granted literature
Information query